Ledger.Open graph →
SEC Form D · filed March 24, 2017

Genoa Pharmaceuticals, Inc

Offering
$62.9M
Sold
$16.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Mark W. Surber, Ph.D · San Diego, CAExecRichard G. Vincent · San Diego, CAExecNaveed G. Siddiqi · San Diego, CADirectorBruce G. Montgomery, M.D · San Diego, CAExec · DirectorTiba G. Aynechi · San Diego, CADirectorJonathan G. Leff, M.D · San Diego, CADirectorKetan G. Patel · San Diego, CADirectorNiall G. O'Donnell · San Diego, CADirectorDavid Judelson · San Diego, CAExecTripp J. Keber · DENVER, COExecDaniel C. Hunt · DENVER, COExecNaveed G. Siddiqi · San Diego, CADirectorBruce G. Montgomery, M.D · San Diego, CAExec · DirectorTiba G. Aynechi · San Diego, CADirectorJonathan G. Leff, M.D · San Diego, CADirectorKetan G. Patel · San Diego, CADirectorNiall G. O'Donnell · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗